Sanuwave Health (SNWV) Stock Statistics & Valuation Metrics

Sanuwave Health has a market cap or net worth of $144.03M. The enterprise value is $139.92M.

Sanuwave Health has 8,598,976 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sanuwave Health’s return on equity (ROE) is 7.30 and return on invested capital (ROIC) is 19.41%.

The current PE Ratio of Sanuwave Health is ―. Sanuwave Health’s PEG ratio is -0.18.

In the last 12 months, Sanuwave Health had revenue of 44.05M and earned 11.81M in profits. Earnings per share was 1.38.

In the last 12 months, operating cash flow was 5.79M and capital expenditures 73.00K, giving a free cash flow of 5.86M billion.

Sanuwave Health pays an annual dividend of ―, resulting in a dividend yield of ―

Sanuwave Health upcoming earnings date is Aug 18, 2026, TBA (Confirmed).

Sanuwave Health as a current ratio of 1.38, with Debt / Equity ratio of 390.59%

In the past 12 months, Sanuwave Health has paid 86.00K in taxes.

Sanuwave Health EV to EBITDA ratio is 13.72, with an EV/FCF ratio of 137.82.

Sanuwave Health has $10.78M in cash and marketable securities with $7.18M in debt, giving a net cash position of $3.60M billion.

Gross margin is 75.68%, with operating margin of 11.23%, and net profit margin of 26.82%.

The average price target for Sanuwave Health is $51.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy